Related Experiment Videos
Idiopathic intracranial hypertension
K Radhakrishnan1, J E Ahlskog, J A Garrity
1Department of Neurology, Mayo Clinic Rochester, MN 55905.
Mayo Clinic Proceedings
|February 1, 1994
Summary
Idiopathic intracranial hypertension (IIH) affects 1-2 per 100,000 people, particularly obese women. Early diagnosis and treatment are crucial for preventing vision loss in this condition.
Area of Science:
- Neurology
- Ophthalmology
Background:
- Idiopathic intracranial hypertension (IIH) is a neurological disorder characterized by increased intracranial pressure without a clear cause.
- The condition disproportionately affects obese women of reproductive age, leading to significant morbidity, including vision loss.
Purpose of the Study:
- To review recent advancements in the epidemiology, diagnostic criteria, and therapeutic strategies for idiopathic intracranial hypertension.
- To provide an updated overview of IIH, encompassing its pathophysiology, complications, and management.
Main Methods:
- A comprehensive literature review of idiopathic intracranial hypertension (IIH) was conducted, focusing on studies published in major English-language journals over the past 20 years.
- The review synthesized information on IIH diagnosis, epidemiology, pathophysiology, complications, and treatment.
Main Results:
- IIH incidence is 1-2 per 100,000 annually, rising to 19-21 in obese reproductive-age females.
- Diagnosis requires elevated intracranial pressure, normal CSF, and normal neuroimaging.
- Pathophysiology involves brain edema and impaired CSF outflow, potentially worsened by venous sinus compression.
Conclusions:
- Medical management is effective for most IIH patients, but surgical intervention is vital for those with progressive vision loss.
- A practical approach to IIH diagnosis, visual impairment detection, and targeted therapy is essential for vision preservation.